This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp.. Active years: 2004-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bridgewater, NJ (US) (2004)
- Hillsborough, NJ (US) (2010)
Company Filing History:


Years Active: 2004-2010
Title: Manomi A Tennakoon: Innovator in Antimicrobial Research
Introduction
Manomi A Tennakoon is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of antimicrobial research, holding a total of 2 patents. His work focuses on developing innovative solutions to combat bacterial infections.
Latest Patents
Tennakoon's latest patents include groundbreaking inventions such as antimicrobial oxazolidinone prodrugs. This invention features oxazolidinone prodrug compounds of Formula (I) and Formula (II), which are convertible by natural biological processes into an active ingredient with antimicrobial properties. These properties are particularly useful in treating bacterial infections in mammals. Another significant patent is for 6-O-acyl ketolide antibacterials, which further showcases his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Tennakoon has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of antimicrobial therapies.
Collaborations
Tennakoon has collaborated with several professionals in his field, including Mark J Macielag and Todd C Henninger. These collaborations have played a crucial role in enhancing his research and expanding the impact of his inventions.
Conclusion
Manomi A Tennakoon is a distinguished inventor whose work in antimicrobial research has led to significant advancements in the treatment of bacterial infections. His patents reflect his dedication to innovation and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile